As UK-led negotiations on fairer sharing of biodiversity data continue at COP16, leading pharma companies have allegedly lobbied government against proposals for a mandatory levy
Asthma inhalers account for almost half the pharma giant's carbon footprint, but a new formula promises to slash emissions from the technology by 90 per cent
UK firms AstraZeneca and GSK among companies to form new task force designed to firm up emissions standards for health sector and reduce emissions generated by pharmaceutical suppliers
New 'Energize' programme designed and delivered by Schneider Electric aims to facilitate decarbonisation of electricity for pharma giants' European and US suppliers
$1bn 'Ambition Zero Carbon' aims for zero carbon emissions across global operations by 2025, and ensure entire value chain is carbon negative by 2030
The global pharmaceuticals behemoth is planning to reduce emissions by 40 per cent by 2025, CEO Christophe Weber announced yesterday